SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

EPT Disclosure

12 May 2009 09:28

RNS Number : 0875S
Credit Suisse Securities (Eur) Ltd
12 May 2009
 

FORM 38.5 (b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION 

Name of exempt principal trader

Credit Suisse Securities (Europe) Limited

Company dealt in

Raven Russia Limited

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary Shares

Date of dealing

11-May-2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

19290

0.004

 

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell 

 

 

 

 

Total

19290

0.004

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 

Class Of Relevant Security : 

Long

Short

(1) Relevant Securities 

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase\sell 

 

 

Total

 

 

(c) Rights to subscribe (Note 2) 

Class of relevant security:

Details

 

 

3. DEALINGS (Note 3)

(a) Purchases and sales 

Purchase/sale

Number of securities

Price per unit (Note 4)

Buy

10000

0.275 (GBP)

Buy

4169

0.275 (GBP)

Buy

1163

0.275 (GBP)

Buy

1100

0.275 (GBP)

Buy

1090

0.275 (GBP)

Buy

583

0.2725 (GBP)

Buy

469

0.275 (GBP)

Buy

322

0.275 (GBP)

Buy

200

0.275 (GBP)

Buy

194

0.275 (GBP)

(b) Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

 

 

 

(c) Options transactions in respect of existing securities 

(i) Writing, selling, purchasing or varying 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

(ii) Exercising 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

(d) Other dealings (including new securities) (Note 3) 

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

 

 

 

4. OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8)  No

Date of disclosure

12-May-2009 07:56:11

Contact name

Collins,Carolyn/ Crawley, Simon

Telephone number

44 20 7888 0241

Name of offeree/offeror with which connected

Raven Russia Limited

Nature of connection (Note 9)

BROKER

Notes  The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSFWSAESUSEEI
Date   Source Headline
21st Aug 20193:00 pmRNSHolding(s) in Company
20th Aug 20193:00 pmRNSResult of General Meeting and Class Meetings
8th Aug 20197:00 amRNSPreference Share Dividend (RAVP)
2nd Aug 20197:00 amRNSBlock listing Interim Review
1st Aug 20193:00 pmRNSHolding(s) in Company
31st Jul 20196:30 pmRNSPublication of circulars
30th Jul 20197:00 amRNSProperty Valuation Update
24th Jul 20197:00 amRNSUpdate on Conditional Purchase of Ordinary Shares
1st Jul 20198:42 amRNSTransaction in Own Shares
1st Jul 20198:00 amRNSTransaction in Own Shares
1st Jul 20197:00 amRNSTotal Voting Rights
28th Jun 20197:00 amRNSIssue of Preference Shares
14th Jun 20193:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20197:00 amRNSTotal Voting Rights
31st May 20193:00 pmRNSResult of AGM
30th May 20197:00 amRNSConvertible Preference Share Dividend (RAVC)
24th May 201910:15 amRNSTender Offer price in Rand
23rd May 20197:00 amRNSScrip Dividend Circular (RAVP)
17th May 20194:40 pmRNSSecond Price Monitoring Extn
17th May 20194:35 pmRNSPrice Monitoring Extension
9th May 20197:00 amRNSPreference Share Dividend (RAVP)
29th Apr 20194:00 pmRNSNotice of AGM and Tender Offer
2nd Apr 20193:30 pmRNSDirectors' Dealings
1st Apr 20197:05 amRNSDirector's Dealing
1st Apr 20197:00 amRNSTotal Voting Rights
29th Mar 20197:00 amRNSIssue of New Preference Shares (RAVP)
28th Mar 20194:30 pmRNSDirector's Dealing
18th Mar 201910:00 amRNSTotal Voting Rights
18th Mar 20197:00 amRNSFinal Results
1st Mar 201911:00 amRNSTotal Voting Rights
28th Feb 20197:00 amRNSConvertible Preference Share Dividend (RAVC)
21st Feb 20197:00 amRNSScrip Dividend Circular
11th Feb 20197:00 amRNSExpiry and Delisting of Warrants
7th Feb 20197:00 amRNSPreference Share Dividend (RAVP)
4th Feb 201910:30 amRNSBlock listing - six monthly return
1st Feb 20197:00 amRNSTotal Voting Rights
9th Jan 20194:40 pmRNSSecond Price Monitoring Extn
9th Jan 20194:35 pmRNSPrice Monitoring Extension
2nd Jan 20197:00 amRNSTotal Voting Rights
31st Dec 20187:00 amRNSDirector/PDMR Shareholding
28th Dec 20189:30 amRNSIssue of Preference Shares
20th Dec 201811:00 amRNSAcquisition
14th Dec 20187:00 amRNSDirector's Dealing
12th Dec 201810:30 amRNSDirector's Dealing
5th Dec 20188:00 amRNSAcquisition
3rd Dec 20187:00 amRNSTotal Voting Rights
29th Nov 20187:00 amRNSConvertible Preference Share Dividend (RAVC)
22nd Nov 20187:00 amRNSScrip Dividend Circular (RAVP)
21st Nov 20186:04 pmRNSDirector/PDMR Shareholding
12th Nov 20183:00 pmRNSUpdate to conversion factor (RAVC)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.